Additionally, in MCF−7 cells, it has been reported that the inhibition of MTH1 increases the proportion of CD44+ CD24−/Low cell subpopulations, suggesting that MTH1 inhibition enhances the number of breast cancer stem cells [37]. This evidence concerns the gene CD44 and breast carcinoma.